Skip to main content
Year archive

argenx SE — 2019 filings

All 56 regulatory filings released by argenx SE (1AE) in 2019, sourced directly from the official regulator.

56 Filings
2019 Period
2019 filings (56)
Filing Released Lang
argenx announces publication of efgartigimod Phase 2 primary immune thrombocytopenia trial results in American Journal of Hematology
Regulatory Filings
2019-12-11 English
6-K
Foreign Filer Report
2019-12-09 English
argenx Announces Receipt of First Milestone Payment under Janssen Collaboration and Provides Data Update from Phase 1 Dose Escalation Trial of Cusatuzumab in Acute Myeloid Leukemia at ASH Annual Meeti
M&A Activity
2019-12-09 English
argenx Announces Upcoming Investor Events
Regulatory Filings
2019-11-26 English
argenx announces results of Extraordinary General Meeting of Shareholders
Declaration of Voting Results & Voting Rights Announcements
2019-11-25 English
argenx announces closing of global offering
Capital/Financing Update
2019-11-13 English
6-K
Foreign Filer Report
2019-11-08 English
424B5
Prospectus
2019-11-08 English
argenx announces full exercise of underwriters’ option to purchase additional ADSs
Share Issue/Capital Change
2019-11-08 English
argenx announces launch of proposed global offering
Share Issue/Capital Change
2019-11-07 English
argenx raises $484 million in gross proceeds in a global offering
Capital/Financing Update
2019-11-07 English
424B5
Prospectus
2019-11-06 English
argenx to Present Data at Upcoming 61st American Society of Hematology (ASH) Annual Meeting
Investor Presentation
2019-11-06 English
6-K
Foreign Filer Report
2019-11-06 English
argenx to Participate in Upcoming Investor Conferences
Investor Presentation
2019-10-30 English
6-K
Foreign Filer Report
2019-10-24 English
argenx reports third quarter 2019 financial results and provides business update
Earnings Release Q3 2019
2019-10-24 English
6-K
Foreign Filer Report
2019-10-15 English
Invitation to the extraordinary shareholders’ meeting
AGM Information
2019-10-14 English
Interim / Quarterly Report 2019
Interim / Quarterly Report H1 2019
2019-09-19 English
argenx to Present at Morgan Stanley 17th Annual Global Healthcare Conference September 3, 2019
Investor Presentation
2019-09-03 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-08-12 English
argenx to Present at 2019 Wedbush PacGrow Healthcare Conference
Report Publication Announcement
2019-08-06 English
Foreign Filer Report 2019
Foreign Filer Report
2019-08-01 English
argenx reports half year 2019 financial results and second quarter business update
Earnings Release H1 2019
2019-08-01 English
argenx to report half year 2019 financial results and second quarter business update on August 1, 2019
Earnings Release H1 2019
2019-07-25 English
argenx to Present at Upcoming Investor Conferences
Regulatory Filings
2019-05-30 English
6-K
Foreign Filer Report
2019-05-28 English
argenx announces publication of efgartigimod Phase 2 myasthenia gravis trial results in Neurology
Earnings Release Q2 2019
2019-05-28 English
6-K
Foreign Filer Report
2019-05-22 English
argenx announces pipeline expansion and “argenx 2021” vision to build integrated immunology company at 2019 R&D Day
Earnings Release Q2 2019
2019-05-22 English
argenx to Host R&D Day on May 22, 2019
Regulatory Filings
2019-05-15 English
Regulatory Filings 2019
Regulatory Filings
2019-05-09 English
6-K
Foreign Filer Report
2019-05-09 English
argenx reports first quarter 2019 financial results and provide business update
Earnings Release Q1 2019
2019-05-09 English
6-K
Foreign Filer Report
2019-05-08 English
argenx to Present at Bank of America Merrill Lynch 2019 Health Care Conference
Report Publication Announcement
2019-05-08 English
argenx announces results of Annual General Meeting of Shareholders
AGM Information
2019-05-07 English
Annual Report 2018
Annual Report FY 2018
2019-04-23 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-04-10 English
20-F
Annual Report FY 2018
2019-03-26 English
6-K
Foreign Filer Report
2019-03-26 English
argenx announces Annual General Meeting of Shareholders on May 7
AGM Information
2019-03-26 English
6-K
Foreign Filer Report
2019-03-14 English
argenx to receive first clinical milestone payment for product candidate developed under option agreement with AbbVie
Regulatory Filings
2019-03-14 English
argenx to Present at Cowen and Company 39th Annual Health Care Conference
Report Publication Announcement
2019-03-04 English
6-K
Foreign Filer Report
2019-02-28 English
argenx reports fourth quarter business update and full year 2018 financial results
Earnings Release FY 2018
2019-02-28 English
argenx to host conference call & webcast to report fourth quarter business update and full year 2018 financial results on February 28, 2019
Earnings Release Q4 2018
2019-02-21 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-02-14 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-02-13 English
6-K
Foreign Filer Report
2019-02-04 English
argenx and Halozyme enter global collaboration and license agreement for ENHANZE® technology
Capital/Financing Update
2019-02-04 English
argenx announces closing of exclusive global collaboration and license agreement for cusatuzumab (ARGX-110) with Janssen
Capital/Financing Update
2019-01-21 English
6-K
Foreign Filer Report
2019-01-18 English
argenx to Present at 37th Annual J.P. Morgan Healthcare Conference
Regulatory Filings
2019-01-03 English